研发投入100-150亿!广药集团与慕恩生物达成合作

动脉生物制造
Dec 29, 2025

2025年12月27日,根据企业官微信息,慕恩生物与广药集团达成战略合作,前者是国内领先微生物发掘与生物制造平台型企业,后者则是世界500强综合性医药健康产业集团。这场合作的基石,建立在双方高度互补的资源与能力之上。慕恩生物,这家成立十年的生物制造企业,以其庞大的微生物菌种资源库和产业化平台而闻名。慕恩生物建立了全球最大、生物多样性最高的微生物菌种资源库之一,保存了超过35万株株功能菌株。依托其...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10